New study: Poor pharmaceutical communication with Hispanic patients affect quality of care

NewsGuard 100/100 Score
A new study revealed that poor communication with Hispanic patients is adversely affecting the quality of care to this country's largest minority group.  The Jeffrey Group, the largest independent communications agency targeting Latin audiences, and KCI Partners, a strategic market research and consulting firm, announced today the results of this study measuring the knowledge and perceptions of minority patients relating to healthcare issues.  The main focus of the study, which surveyed 422 physicians across the country, was to uncover barriers in receiving adequate treatment and measure the effectiveness of communication vehicles in educating Hispanic patients about their health.

"Given the prevalence of topics such as healthcare reform and the much-awaited U.S. Census results, we felt it was perfect timing to conduct a study measuring the views and knowledge-base of average Hispanic patients," said Mike Valdes-Fauli, President of The Jeffrey Group.  "With a booming U.S. Hispanic population, it is important to identify best practices in communicating with Latinos to ensure optimal care, and hopefully provide insights to pharmaceutical companies seeking to inform and educate that audience."

One of the most important findings of the study was related to obstacles physicians encountered in effectively treating Hispanic patients.  Twenty-four percent of physicians cited poor patient understanding of disease severity was "almost always a barrier" to treatment and 21% cited it as "frequently a barrier."  Other factors cited by physicians as almost always being a barrier to treatment were preconceived notions/myths (23% of physicians) and conflicting advice about treatment from family members (21% of physicians).

Despite these barriers, nearly 50% of respondents cited that community organizations, physicians, physician assistants and nurses are among those doing the most effective job at communicating about healthcare issues with Hispanic patients.  On the other hand, most physicians think that pharmaceutical companies do a poor job of communicating, lacking a thorough understanding of multicultural patient needs. In fact, only 12% reported that pharmaceutical companies understand the healthcare needs of Hispanic patients very well.  Even fewer physicians (7%) indicated that pharmaceutical companies are doing an adequate job in communicating with Hispanics about solutions to their healthcare needs.

The second part of the study addressed the most effective educational vehicles for informing Hispanic or minority patients. Most physicians agree that one-on-one time with staff and printed educational materials in Spanish are the most important and effective ways to communicate with these patients.  Furthermore, physicians agree that media plays a key role in informing patients.  Seventy-one percent of physicians cited that, outside of their offices, television stories are a very or extremely effective communication vehicle to help educate these patients.

The data from this study can be used to improve healthcare delivery and enhance the comfort level of minority patients across the country," said  Richard Klass, President of KCI.

Source:

The Jeffrey Group; KCI Partners

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Common HIV drugs linked to reduced Alzheimer's disease risk